Eton Pharmaceuticals, Inc. (ETON)
ETON Stock Price Chart
Explore Eton Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze ETON price movements and trends.
ETON Company Profile
Discover essential business fundamentals and corporate details for Eton Pharmaceuticals, Inc. (ETON) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
14 Nov 2018
Employees
44.00
Website
https://www.etonpharma.comCEO
Sean E. Brynjelsen
Description
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.
ETON Financial Timeline
Browse a chronological timeline of Eton Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 6 Aug 2026
EPS estimate is $0.13, while revenue estimate is $27.11m.
Earnings released on 14 May 2026
EPS came in at $0.05 falling short of the estimated $0.10 by -50.00%, while revenue for the quarter reached $24.27m , beating expectations by +8.76%.
Earnings released on 19 Mar 2026
EPS came in at $0.05 falling short of the estimated $0.12 by -58.33%, while revenue for the quarter reached $21.28m , beating expectations by +6.53%.
Earnings released on 6 Nov 2025
EPS came in at -$0.07 falling short of the estimated $0.16 by -143.75%, while revenue for the quarter reached $22.46m , beating expectations by +9.70%.
Earnings released on 7 Aug 2025
EPS came in at -$0.10 falling short of the estimated -$0.01 by -900.00%, while revenue for the quarter reached $18.93m , missing expectations by -7.55%.
Earnings released on 13 May 2025
EPS came in at $0.07 falling short of the estimated $0.09 by -22.22%, while revenue for the quarter reached $17.28m , beating expectations by +14.22%.
Earnings released on 18 Mar 2025
EPS came in at -$0.02 matching the estimated -$0.02, while revenue for the quarter reached $11.65m , missing expectations by -18.73%.
Earnings released on 12 Nov 2024
EPS came in at $0.02 surpassing the estimated $0.00 by +400.00%, while revenue for the quarter reached $10.32m , missing expectations by -1.96%.
Earnings released on 8 Aug 2024
EPS came in at -$0.12 falling short of the estimated -$0.07 by -71.43%, while revenue for the quarter reached $9.07m , missing expectations by -6.36%.
Earnings released on 9 May 2024
EPS came in at -$0.03 surpassing the estimated -$0.07 by +57.14%, while revenue for the quarter reached $7.97m , missing expectations by -9.48%.
Earnings released on 14 Mar 2024
EPS came in at -$0.09 falling short of the estimated -$0.04 by -125.00%, while revenue for the quarter reached $7.31m , missing expectations by -5.03%.
Earnings released on 9 Nov 2023
EPS came in at -$0.02 surpassing the estimated -$0.10 by +80.00%, while revenue for the quarter reached $7.03m , beating expectations by +12.27%.
Earnings released on 10 Aug 2023
EPS came in at $0.15 surpassing the estimated -$0.09 by +266.67%, while revenue for the quarter reached $12.00m , beating expectations by +18.90%.
Earnings released on 11 May 2023
EPS came in at -$0.10 surpassing the estimated -$0.14 by +28.57%, while revenue for the quarter reached $5.30m , missing expectations by -18.53%.
Earnings released on 16 Mar 2023
EPS came in at $0.04 surpassing the estimated $0.01 by +300.00%, while revenue for the quarter reached $8.50m , beating expectations by +86.36%.
Earnings released on 10 Nov 2022
EPS came in at -$0.12 surpassing the estimated -$0.15 by +20.00%, while revenue for the quarter reached $3.22m , beating expectations by +5.58%.
Earnings released on 11 Aug 2022
EPS came in at -$0.06 falling short of the estimated -$0.02 by -300.00%, while revenue for the quarter reached $7.36m , missing expectations by -5.67%.
Earnings released on 12 May 2022
EPS came in at -$0.21 falling short of the estimated -$0.08 by -162.50%, while revenue for the quarter reached $2.18m , beating expectations by +6.67%.
Earnings released on 16 Mar 2022
EPS came in at $0.04 falling short of the estimated $0.19 by -78.95%, while revenue for the quarter reached $6.09m .
Earnings released on 15 Nov 2021
EPS came in at -$0.24 falling short of the estimated -$0.14 by -71.43%, while revenue for the quarter reached $775.00k , beating expectations by +16.72%.
Earnings released on 16 Aug 2021
EPS came in at -$0.08 surpassing the estimated -$0.14 by +42.86%, while revenue for the quarter reached $3.07m , missing expectations by -35.57%.
ETON Stock Performance
Access detailed ETON performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
